203 related articles for article (PubMed ID: 33259227)
21. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.
Singer AJ; Xiang J; Kabrhel C; Merli GJ; Pollack C; Tapson VF; Wildgoose P; Peacock WF
Acad Emerg Med; 2016 Nov; 23(11):1280-1286. PubMed ID: 27537530
[TBL] [Abstract][Full Text] [Related]
22. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
Fermann GJ; Erkens PM; Prins MH; Wells PS; Pap ÁF; Lensing AW
Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
[TBL] [Abstract][Full Text] [Related]
23. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
Hull RD
Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
[TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
[TBL] [Abstract][Full Text] [Related]
25. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
[TBL] [Abstract][Full Text] [Related]
26. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
27. Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis.
Kabrhel C; Rosovsky R; Baugh C; Connors J; White B; Giordano N; Torrey J; Deadmon E; Parry BA; Hagan S; Zheng H
Acad Emerg Med; 2019 Jun; 26(6):657-669. PubMed ID: 30341928
[TBL] [Abstract][Full Text] [Related]
28. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
Aujesky D; Roy PM; Verschuren F; Righini M; Osterwalder J; Egloff M; Renaud B; Verhamme P; Stone RA; Legall C; Sanchez O; Pugh NA; N'gako A; Cornuz J; Hugli O; Beer HJ; Perrier A; Fine MJ; Yealy DM
Lancet; 2011 Jul; 378(9785):41-8. PubMed ID: 21703676
[TBL] [Abstract][Full Text] [Related]
29. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
Maestre A; Trujillo-Santos J; Riera-Mestre A; Jiménez D; Di Micco P; Bascuñana J; Vela JR; Peris L; Malfante PC; Monreal M;
Ann Am Thorac Soc; 2015 Aug; 12(8):1122-9. PubMed ID: 26114586
[TBL] [Abstract][Full Text] [Related]
30. Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.
Chopard R; Andarelli JN; Humbert S; Falvo N; Morel-Aleton M; Bonnet B; Napporn G; Kalbacher E; Obert L; Degano B; Cappelier G; Cottin Y; Schiele F; Meneveau N
Thromb Res; 2019 Feb; 174():27-33. PubMed ID: 30553162
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Chest; 2020 Mar; 157(3):636-644. PubMed ID: 31605702
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors of venous thromboembolism recurrence and the predictive value of simplified pulmonary embolism severity index in medical inpatients].
Shi CL; Zhou HX; Tang YJ; Wang L; Yi Q; Liang ZA
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1112-5. PubMed ID: 27095779
[TBL] [Abstract][Full Text] [Related]
33. Factor Xa inhibition and sPESI failure in intermediate-high-risk pulmonary embolism.
Trevino AR; Perez L; Jerjes-Sanchez C; Rodriguez D; Panneflek J; Ortiz-Ledesma C; Nevarez F; Jimenez V; Valdes F; de Obeso E
Am J Emerg Med; 2018 Oct; 36(10):1925.e3-1925.e4. PubMed ID: 29958743
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism.
Aujesky D; Smith KJ; Cornuz J; Roberts MS
Chest; 2005 Sep; 128(3):1601-10. PubMed ID: 16162764
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Volumetric Comparison of Direct Oral Anticoagulant and Vitamin K Antagonist Treatment for Pulmonary Thrombus Reduction During the Acute Phase in Symptomatic Patients.
Jujo K; Yoshida A; Fukushima K; Kikuchi Y; Minami Y; Murasaki K; Haruki S; Sekiguchi H; Tanaka H; Ogawa H; Hagiwara N
Am J Med Sci; 2020 Aug; 360(2):153-160. PubMed ID: 32563568
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review.
Janjua M; Badshah A; Matta F; Danescu LG; Yaekoub AY; Stein PD
Thromb Haemost; 2008 Nov; 100(5):756-61. PubMed ID: 18989517
[TBL] [Abstract][Full Text] [Related]
37. Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients.
Fung KP; Chan KH; Ng V; Tsui PT; You JHS
Cardiovasc Drugs Ther; 2019 Jun; 33(3):331-337. PubMed ID: 30888571
[TBL] [Abstract][Full Text] [Related]
38. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
Barco S; Lankeit M; Binder H; Schellong S; Christ M; Beyer-Westendorf J; Duerschmied D; Bauersachs R; Empen K; Held M; Schwaiblmair M; Fonseca C; Jiménez D; Becattini C; Quitzau K; Konstantinides S
Thromb Haemost; 2016 Jul; 116(1):191-7. PubMed ID: 27010343
[TBL] [Abstract][Full Text] [Related]
39. Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
Chopard R; Badoz M; Eveno C; Ecarnot F; Falvo N; Kalbacher E; Capellier G; Guillon B; Schiele F; Meneveau N
Thromb Res; 2020 Dec; 196():476-482. PubMed ID: 33091699
[TBL] [Abstract][Full Text] [Related]
40. Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States.
Guo JD; Hlavacek P; Poretta T; Wygant G; Lane D; Gorritz M; Wang X; Chen CC; Wade RL; Pan X; Rajpura J; Stwalley B; Rosenblatt L
J Thromb Thrombolysis; 2020 Aug; 50(2):386-394. PubMed ID: 31955338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
